Abbott: Abbott announces positive latebreaking data from TRILUMINATE trial of TriClip transcatheter edgetoedge repair system to treat tricuspid regurgitation
Abbott, a global healthcare leader that helps people live more fully at all stages of life, announced late─breaking data from its TRILUMINATE pivotal trial that show the TriClip transcatheter edge─to─edge repair
Read full article »
Chairman & CEO
Robert B. Ford
Abbott is an Illinois-based healthcare company that develops and markets medical devices in fields such as neuroscience and diabetes.
Read more